Chinook Therapeutics Inc logo

Chinook Therapeutics Inc Share Price (NASDAQ: KDNY)

▲

-40.39

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 10 Aug 2023

Check the interactive Chinook Therapeutics Inc Stock chart to analyse performance

Chinook Therapeutics Inc Key Stats

Check Chinook Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$40.39
Open
$40.31
Market Capitalization
$2.7B
Today's Volume
$4.9M
Revenue TTM
$5.3M
EBITDA
$-197.0M
Earnings Per Share (EPS)
$-3.24
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-51.56%

Global Institutional Holdings in Chinook Therapeutics Inc

  • Name

    Holdings %

  • Samsara BioCapital, LLC

    7.70%

  • BlackRock Inc

    5.88%

  • Deep Track Capital, LP

    4.47%

  • Vanguard Group Inc

    4.25%

  • State Street Corporation

    4.01%

  • Octagon Capital Advisors LP

    3.81%

Analyst Recommendation on Chinook Therapeutics Inc Stock

Rating
Trend

Hold

    47%Buy

    52%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Chinook Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Chinook Therapeutics Inc

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.
Organization
Chinook Therapeutics Inc
Employees
214
CEO
Mr. Eric L. Dobmeier J.D.
Industry
Health Technology

Important FAQs about investing in KDNY Stock from India :

What is Chinook Therapeutics Inc share price today?

Chinook Therapeutics Inc share price today is as on at the close of the market. Chinook Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Chinook Therapeutics Inc share?

Chinook Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Chinook Therapeutics Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Chinook Therapeutics Inc Stock (KDNY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Chinook Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Chinook Therapeutics Inc Shares .

What is the minimum amount required to buy Chinook Therapeutics Inc Stock (KDNY) from India?

Indian investors can start investing in Chinook Therapeutics Inc (KDNY) shares with as little as ₹88.3 or $1 (as of September 13, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹883.00 in Chinook Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 13, 2025). Learn more about fractional shares .

What are the returns that Chinook Therapeutics Inc has given to Indian investors in the last 5 years?

Chinook Therapeutics Inc stock has given 0.0% share price returns and 20.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?